Haleon Archives -

Pharma companies involved in the sale of heartburn therapy Zantac have won a key battle in litigation brought

US court throws out lawsuits alleging Zantac caused cancer

https://pharmaphorum.com/news/us-court-throws-out-lawsuits-alleging-zantac-caused-cancer/

The first lawsuit claiming that gastrointestinal drug Zantac causes cancer has been voluntarily dismissed a week before it

First Zantac cancer case dropped before trial, without settlement

https://pharmaphorum.com/news/first-zantac-cancer-case-dropped-before-trial-without-settlement/

GSK, its consumer health spin-off Haleon, and Sanofi could be on the hook for billions of dollars in

GSK, Sanofi and Haleon ‘facing billions of dollars in Zantac liability’

https://pharmaphorum.com/news/gsk-sanofi-and-haleon-facing-billions-of-dollars-in-zantac-liability/

In its first set of financial figures since spinning off its consumer health division, GSK has reported a

Record Shingrix sales help GSK raise 2022 forecasts

https://pharmaphorum.com/news/record-shingrix-sales-help-gsk-raise-2022-forecasts/

GSK’s consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with

GSK consumer health spin-off Haleon starts trading

https://pharmaphorum.com/news/gsk-consumer-health-spin-off-haleon-starts-trading/

GlaxoSmithKline is due to complete the split from its consumer health decision – now renamed Haleon – next

Pfizer will exit GSK consumer health JV after spinout

https://pharmaphorum.com/news/pfizer-will-exit-gsk-consumer-health-jv-after-spinout/

GlaxoSmithKline’s consumer health business will be named Haleon following its planned spinoff and listing on the London Stock

GSK names its consumer health spinoff Haleon

https://pharmaphorum.com/news/gsk-names-its-consumer-health-spinoff-haleon/

Haleon